Abstract Droplet-based liquid microjunction surface sampling coupled with high-performance liquid chromatography (HPLC)-electrospray ionization (ESI)-tandem mass spectrometry (MS/MS) for spatially resolved analysis provides the possibility of effective analysis of complex matrix samples and can provide a greater degree of chemical information from a single spot sample than is typically possible with a direct analysis of an extract. Described here is the setup and enhanced capabilities of a discrete droplet liquid microjunction surface sampling system employing a commercially available CTC PAL autosampler. The system enhancements include incorporation of a laser distance sensor enabling unattended analysis of samples and sample locations of dramatically disparate height as well as reliably dispensing just 0.5 μL of extraction solvent to make the liquid junction to the surface, wherein the extraction spot size was confined to an area about 0.7 mm in diameter; software modifications improving the spatial resolution of sampling spot selection from 1.0 to 0.1 mm; use of an open bed tray system to accommodate samples as large as whole-body rat thin tissue sections; and custom sample/solvent holders that shorten sampling time to approximately 1 min per sample. The merit of these new features was demonstrated by spatially resolved sampling, HPLC separation, and mass spectral detection of pharmaceuticals and metabolites from whole-body rat thin tissue sections and razor blade ("crude") cut mouse tissue.
Introduction
Spatially resolved liquid-solid extractive sampling of surfaces combined with mass spectrometric analysis of the extracts using a continuous-flow liquid microjunction surface sampling probe (CF-LMJ-SSP) was introduced in the early 2000s [1] . This sampling probe was designed to both continuously deliver a liquid extraction solvent to a surface forming a wall-less liquid junction between the probe and the surface and to aspirate away the solvent extract for immediate analysis by electrospray ionization (ESI)-or atmospheric pressure chemical ionization (APCI)-mass spectrometry (MS) [2] . Over the course of the last decade, multiple continuous flow [1] [2] [3] [4] [5] [6] [7] as well as discrete droplet [8, 9] variations of this liquid microjunction surface sampling and analysis approach have been implemented for numerous applications. The increased interest in this spatially resolved surface sampling/analysis methodology is due, in part, to the unrivaled sensitivity compared to other ambient surface sampling techniques [10, 11] , owing to the efficiency of analyte extraction. In addition, some of these liquid microjunction probe/methods allow ready transfer of the sampled material for post-sampling processing, such as a high-performance liquid chromatography (HPLC) separation, prior to mass spectral analysis [5, 9, [12] [13] [14] . Such a configuration enables effective analysis of targeted analytes within complex matrices well as the ability to differentiate isobaric compounds, thus providing a greater degree of chemical information from a single spot sample than is possible with a direct analysis.
With respect to discrete droplet liquid microjunction surface sampling, our group first implemented and continues to advance a system combined with HPLC-MS that utilizes a widely available (CTC PAL) commercial autosampler [9, [12] [13] [14] . This is a standalone system that connects to the existing liquid introduction ionization source (e.g., ESI or APCI) of the mass spectrometer. With this system, sampling is commenced by drawing a predefined amount of extraction solvent from a vial into the autosampler syringe needle (sampling probe) and barrel, followed by switching the needle configuration into surface sampling mode (needle protruding over the needle guide). As illustrated in sections II-V of Fig. 1b , the syringe needle is then positioned at a predefined distance (100-300 μm in general) above a defined surface spot (Fig. 1b, II) and a discrete volume of extraction solvent is dispensed onto a surface creating a liquid junction between the needle and the surface (Fig. 1b, III) . After a predefined extraction time (Fig. 1b, IV) , the liquid is drawn back into the syringe needle (Fig. 1b, V) , followed by switching the needle configuration from surface sampling mode to injection mode (needle leveled with the needle guide), and the analyte transferred to an injector and injected for subsequent Schematic of the surface sampling process including (I) the positioning of the laser beam above a defined surface spot followed by the measurement of the laser sensor-to-surface distance (D) from which syringe tipto-surface distance (D z ) is then calculated using a previously determined and fixed laser sensorto-syringe tip distance (D f ), (II) the positioning of the syringe needle at a predefined distance (d 0 ) above the defined surface spot, (III) dispensing a discrete volume of extraction solvent onto a surface creating a liquid junction between the needle and the surface, (IV) dissolution of the analyte in the extraction solvent, and (V) the liquid is drawn back into the syringe needle after a predefined extraction time chromatographic separation and mass spectral analysis. We have used this instrumentation and various operational methods to determine the spatially resolved, semiquantitative distribution of pharmaceuticals and metabolites in mouse and rat thin tissue sections [9, 12, 13] . During the course of these prior studies, some experimental and practical limitations were identified for improvement. For example, spot sampling size was approximately 1 mm (defined by the diameter of the probe-to-surface liquid junction), but was limited by software to selected locations on the nodes of a grid with a 1-mm node-to-node distance. This inhibited precise selection of sampling location. Studies found that reliable spot sampling required an optimum probe-to-surface distance with a relatively tight tolerance [14] . To remain within this optimum range, the sample height could not vary by more than about 0.2 mm across the surface to be analyzed [14] . Inhomogeneity in sample height due to tilting of the autosampler tray holding the sample or due to the typical double-sided tape mounting of the tissue to a glass slide could easily cause a 0.2-mm variation or more. This fact limited the ability to easily set up and to automatically analyze tissue or any other samples of disparate height. In addition, the overall sample size was limited to what could be placed on a single microliter plate area. For example, whole-body mice tissue could be analyzed [9] , but rat tissues had to be cut in half and analyzed as two separate samples [12, 13] . And finally, extraction solvent vial and sample locations resulted in timeconsuming, complicated, and long-distance robot movements resulting in a sampling time of about 1.7 min. This lengthy time could limit sample throughput if fast chromatographic separations are implemented.
In this paper, we report on the latest enhancements to our discrete droplet liquid microjunction surface sampling system that overcomes these prior deficiencies. These enhancements include incorporation of a laser distance sensor enabling unattended analysis of samples and sample locations of dramatically disparate height, software modifications improving the spatial resolution of sampling spot selection from 1.0 to 0.1 mm, use of an open bed tray system to accommodate samples as large as whole-body rat thin tissue sections, and custom sample/solvent holders that shorten sampling time by about 40 % to approximately 1 min per sample. The merit of these new features was demonstrated by spatially resolved sampling, HPLC separation, and mass spectral detection of pharmaceuticals and metabolites from whole-body rat thin tissue sections and razor blade ("crude") cut mouse tissue. Rat thin tissue sections Male rats (HanWistar, 150-225 g) were dosed orally at a level of 40 and 100 mg/kg with propranolol and acetaminophen, respectively. The dosed rats were sacrificed 2 or 1 h after dose, respectively, using isoflurane anesthesia followed by freezing in a −80°C dry ice/hexane bath. The frozen carcasses were embedded on a microtome mold/stage in an ice-cold aqueous solution of 2 % carboxymethylcellulose for 1 h. The stages were then transferred to a −20°C freezer for a night. Once frozen, five sagittal whole-body cryosections (40 μm thick) at different levels of interest were prepared using a cryomicrotome (model Vibratome, Leica Microsystems GmbH, Wetzlar, Germany). Frozen sections were transferred to a one-sided adhesive tape. Tissue sections were stored at −20°C until analysis. Just prior to analysis, samples were taken out from the freezer and
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Scheme 1 Structure, mass-tocharge ratio, and origin of major product ions for propranolol (1), hydroxypropranolol glucuronide metabolites (1a and 1b) and acetaminophen sulfate (2) allowed to come to room temperature in a desiccator. While the impact of thawing on spatial distribution of the analytes of interests was not evaluated, negligible redistribution of drug and metabolites can be expected due to the use of a desiccator.
Mouse tissue sections Nude NCR mice (n=3) were dosed subcutaneously with 111 μmol/kg (50 mg/kg) of AZ-3 and sacrificed after 2 h for necropsy, in which liver and muscle tissues were removed and snap-frozen (dry ice and isopentane). A control group (n=3) received no compound dose, where necropsy and tissue preparation methods were identical. Tissue slices were taken manually by a sharp razor blade and thaw-mounted onto glass microscope slides, which were stored at −80°C until required. Just prior to analysis, samples were taken out from the freezer and allowed to come to room temperature in a desiccator.
Custom sample trays Custom sample holders, microtiter plates, and double width microtiter plates ( Fig. 1a and Fig. S1 in the Electronic Supplementary Material (ESM)) were designed in AutoCad 2015 (Autodesk, Inc., San Rafael, CA). All holders included a recessed sample region, space for four individual extraction solvent vials, and a smaller-diameter hole used in locking the needle guide to assist with switching the injector needle configuration into surface sampling mode [12, 13] . Multiple trays were printed using either polylactic acid (PLA) or acrylonitrile butadiene styrene (ABS) plastics using either a Solidoodle 3rd generation (Solidoodle LLC, Brooklyn, NY) or a Fortus 900 mc (Stratasys, Eden Prairie, MN) 3D printer.
Surface sampling/HPLC instrumentation and operation The work described herein utilized an HTS-PAL autosampler (LEAP Technologies Inc., Carrboro, NC) equipped with a 100-μL L-MARK® 22s-gauge gastight syringe with a fixed needle (part no. LMK-2620719; 152 μm i.d.; 717 μm o.d.; LEAP Technologies Inc.) and an API 4000™ triple quadrupole mass spectrometer (AB SCIEX, Concord, Ontario, Canada). Communication control and data flow between the instruments are illustrated in ESM Fig. S2 . The autosampler system and setup was similar to that described previously [12] [13] [14] . Changes included addition of a laser distance sensor (model ZX2-LD100, Omron, Hoffman Estates, IL) mounted on the autosampler, use of custom 3D printed sample holders (see above)
, and an open sample tray holder (model PAL.TRHLDLC, LEAP Technologies Inc.; see Fig. 1a ) rather than the previously used cool stack [12] [13] [14] . Samples were mounted in the recess of the custom trays using double-sided tape. The tray with the mounted sample was coupled with a 3D printed "tray riser" (not shown). This part raised the sample off the surface of the flatbed scanner (model Perfection v300 Photo, Epson America Inc., Long Beach, CA, USA) used to obtain an optical image of the surface to be analyzed for software-guided selection of sampling locations using an in-house developed software (LMJ Points Plus©) [12] [13] [14] . The procedures for selection of sampled positions and co-registration of the optical image to these positions were similar to that previously described elsewhere [12] [13] [14] with the difference that locations could be selected with a 0.1-mm precision rather than the previous limit of 1 mm.
Once the surface locations were selected for analysis in LMJ Points Plus©, the user transferred this information into LEAPShell 3™ (LEAP Technologies Inc) by controlling the autosampler via a text file imported into the sample queue of the software. The autosampler method assigned to the queue positioned the laser distance sensor above a surface location to be sampled (Fig. 1b, I ) followed by sending out a TTL signal on one digital output of the autosampler. This signal was sensed by LMJ Points Plus© via a digital input port of a USB-1208LS data acquisition device (Measurement Computing, Norton, MA, USA) that triggered the measurement of the laser sensor-to-surface distance. These distances were collected in the sample list in LMJ Points Plus©, and they were later used for correct positioning of the autosampler syringe needle along the vertical Z-axis (see detailed discussion below). Once the sample queue was completed, the user transferred the surface locations to be analyzed along with distance information collected above from LMJ Points Plus© into LEAPShell 3™ again via a text file imported into the sample queue of the latter software. In addition, the required HPLC/MS acquisition method and MS data file names were also transferred into Analyst™ (AB SCIEX) via a third text file to create an Analyst™ sample queue. Serial sampling of previously selected locations was commenced in LEAPShell 3™. Samples were injected onto a Hydro-RP HPLC column (50×2 mm, 4 μm particle size; Phenomenex, Torrance CA) for subsequent HPLC-ESI-MS/MS analysis employing an Agilent 1100 HPLC pump (Agilent Technologies, Santa Clara, CA) to deliver the separation solvents coupled to the mass spectrometer. HPLC separation solvents A and B were 100/0.1 (v/v) water/FA and 100/0.1 (v/v) ACN/FA, respectively. HPLC separation conditions are listed in Table 1 for all samples. Solution flow rate was 200 μL/min for all experiments. Selected reaction monitoring (SRM) was used to monitor all compounds of interest. Mass spectrometric conditions including electrospray ionization (ESI) mode, emitter voltage (IS), monitored precursor (Q1) and fragment (Q3) masses, collision energy (CE), and declustering potential (DP) are listed in Table 2 . Dwell time was 50 ms for each transition monitored. Turbo sprayer heater temperature was 400°C.
Results and discussion
Laser distance sensing for analysis of samples and sample locations of disparate height To reliably and automatically position the sampling probe the proper distance above a sample for solvent dispense and aspiration, a laser distance sensor was attached to the vertical arm of the robotic autosampler (Fig. 1) . Following selection of the sampling locations with the LMJ Points Plus© software, as described in the "Experimental" section, the robot arm was moved automatically to position the laser sensor sequentially above each selected location where the laser sensor-to-surface distance was measured (Fig. 1b, I ). Using this measured distance (D) and a previously determined vertical offset (D f ) between the laser sensor and the probe (tip of the autosampler syringe needle), the actual probe-to-surface distance (D z =D−D f ) was calculated in LMJ Points Plus©. This D z distance was then used to calculate how far the probe needed to move down vertically during the sampling process (D z −d 0 , Fig. 1b, II) at the specific spot to obtain the predetermined optimal d 0 (0.2 mm in the current study) probe-to-surface distance. The actual surface sampling commenced after all these distance measurements were completed. For each sampling location, the autosampler first drew 5 μL of extraction solvent from a vial in one of the vial holders (indicated by "2" in Fig. 1a ) located on the custom sample tray. This was followed by switching the syringe needle configuration into surface sampling mode using the needle lock hole (indicated by "1" in Fig. 1a ) also located on the custom sample tray. As illustrated in Fig. 1b (II), this step was followed by moving the probe to the optimal d 0 sampling distance from the surface and a specific volume of extraction solvent (see Table 1 ) was dispensed onto the selected surface spot of interest creating a liquid junction (Fig. 1b, III) . After a given extraction time (Fig. 1b, IV and Table 1 ), the solvent with extract was aspirated back into the syringe (Fig. 1b, V) , and the full 5-μL sample was injected onto an HPLC column for subsequent HPLC-ESI-MS/MS analysis.
The data in Fig. 2 illustrates the results of this laser distance sensing and automated analysis using a whole-body rat thin tissue section from an animal dosed with propranolol (40 mg/kg P.O., sacrificed 2 h post dose). The 30 surface locations analyzed (marked with plus signs in Fig. 2a) were expected to exhibit well-defined distributions of the parent drug and its metabolites demonstrating the analytical power of the current method and should not be construed to suggest that these compounds were not distributed to other tissues. The areas selected for analysis included embedded blood spots spiked with different propranolol concentrations (0 to 5000 ng/mL, see Fig. 2b ), parts of the brain, lung, heart (muscle and blood), liver, intestinal lining, rectum, and testis. The spots sampled by using 2 μL of 90/10/0.1 (v/v/v) water/ ACN/FA encompassed an area of approximately 156.4 mm× 40.4 mm in size. Over this area, the surface heights were measured to differ by as much as 1.3 mm between some locations as illustrated by the height difference measurements shown for each spot compared to the unspiked embedded blood sample location (Fig. 2a) . Without automated adjustment of the probe positioning between sampling locations, analysis would have been unsuccessful for any location with a height variation of more than about 0.2 mm compared to this reference point. Visual inspection during the analysis process confirmed in this case that sampling from all 30 locations was successful despite the significant height variations between the sampled spots. From the data collected at each sample location on the tissue section, compound specific abundances of propranolol and two hydroxypropranolol glucuronide metabolites were determined using a procedure described previously [12] [13] [14] . Briefly, LMJ Points Plus© software was provided with filenames and retention time (R t ) ranges for background and peak area calculation for these compounds. In Fig. 2d , the white and gray sections between R t =2−2.5 min and R t =4.6-5.1 min represent the ranges where background signal was sampled and from which background-corrected peak area for propranolol (R t =4.7 min) was calculated, respectively. Similarly, white and gray sections between R t =2−2.5 min and R t =4.2−4.5 min in Fig. 2e indicate retention time ranges from which peak area for aliphatic hydroxypropranolol glucuronide metabolites (cpd 1b in Scheme 1, R t =4.3 min) was calculated. (Note that spatial distribution profiles and relative abundances for both hydroxypropranolol glucuronide metabolites, i.e., cpds 1a (see Scheme 1) and 1b, in all areas of the tissue section were found to be very similar [9] . For that reason, the discussion of metabolite results is limited to the Gray and white sections show the time ranges used for peak integration (R t =4.6−5.1 min and R t =4.2−4.5 min for cpds 1 and 1b, respectively) and background calculation (R t =2− 2.5 min for both cpds), respectively, when creating heat maps in b and c, respectively aliphatic hydroxypropranolol glucuronide metabolite.) Integrated HPLC-ESI-MS/MS peak areas for the parent drug and the metabolite are presented in Fig. 2b , c, respectively, as circles with a false color scale (heat maps). The diameter of the circles was set to the liquid junction diameter (about 2 mm) at the various sampling locations. In this case, a logarithmic intensity color scale was used to reflect the relative integrated HPLC-ESI-MS/MS peak areas measured [12] . The heat maps for the spiked blood indicated that there was an increase in signal for propranolol with increased spike level (Fig. 2b) .
Plotting the peak area of propranolol as a function of its spiked concentration for these blood samples showed a linear relationship (ESM Fig. S3 ), proving that the analytical results observed are expected to be at least semiquantitative. In addition, spatial distribution profiles presented in subpanels b and c of Fig. 2 for the parent drug and metabolite, respectively, were in agreement with those observed previously using various liquid extractionbased surface sampling methods to analyze tissues of mice dosed following a similar dosing protocol as described here [8, 9, 15, 16] and using tissues made from the same animal [12] . Only the parent drug was found in the brain and the intestinal lining exhibited both the parent drug and the metabolite in the largest amounts. An additional benefit not obvious from just the displayed data is the time savings accrued by the use of the custom sample and vial holder. This change in the system reduced the sampling process from about 1.7 min [12] [13] [14] by about 40 % to 1 min per sample. Over the course of the analysis of the 30 samples, that savings equated to about 20 min or a 10 % reduction in analysis time, which was ultimately limited by the 6-min chromatography currently employed.
Sample location selection spatial resolution The spatial resolution of sample spot selection was improved from 1.0 to 0.1 mm with this version of our system. This enabled the ability to sample much more precisely specific locations on a surface.
In a previous study, we observed the sulfate metabolite of acetaminophen (cpd 2 in Scheme 1) in the small gastrointestinal tract and what appeared to be in a vein in the liver, but not in the liver tissue from a rat dosed with acetaminophen (100 mg/kg P.O., sacrificed 1 h post dose) [13] . That observed distribution was likely due to hepatic metabolism and biliary excretion of acetaminophen sulfate into the small intestine. Unfortunately, the 1.0-mm precision of spot selection available in that study limited exact sampling from the small-sized veins visible in the liver. Figure 3a shows an optical image of a rat thin tissue section from the same rat used in that prior study with portions of the liver, spine, and lung visible. Evident within the liver are the locations of several veins. The zoomed-in image in Fig. 3b corresponds to one of these veins marked by a black rectangle in Fig. 3a . Superimposed on this image of the roughly 1 mm wide×4 mm long teardrop-shaped vein are 25 white crosses showing the surface locations selected for sampling. The ability to select the sampling location with a 0.1-mm precision allowed for selection of sampling locations centered in the 1.0-mm-wide feature of interest. The remaining locations were on the nodes of a 5×5 grid with a 0.5-mm spacing and were picked to include surface locations located both in the liver tissue and as well as in the vein. By dispensing just 0.5 μL of 90/10/0.1 (v/v/v) water/ACN/FA extraction solvent to make the liquid junction to the surface, the extraction spot size was confined to an area about 0.7 mm in diameter (the outer diameter of the syringe needle), justifying the close sample location spacing.
The spatial distribution linear intensity heat map for acetaminophen sulfate determined from the HPLC-ESI-MS/MS data (ESM Fig. S4 ) at these sampling locations is shown in and c heat map of cpd 2 (peak, R t =3−4 min; background, R t =0.5−1 min). The linear intensity color scale used to create the heat map is shown in the bottom right corner; 100 % intensity corresponds to 1.02×10 5 counts Fig. 3c . These data confirm that the distribution of the sulfate metabolite was restricted to the vein region of the liver tissue.
Analysis of razor blade ("crude") cut tissue sections Crude cut or biopsy tissue represent other types of tissues that might be prepared for analysis that are of disparate height. The size of these tissue can also be relatively small (e.g., 1 mm width) such that spot selection with a precision of 0.1 mm is required for effectively sampling. Figure 4a shows an optical image of crude cut muscle and liver tissues harvested from both a nondosed mouse and a mouse dosed with AZ-3 (50 mg/kg, dosed subcutaneously, sacrificed 2 h after dose). Sampling locations are indicated in the figure by black crosses with the relative height differences among the sampling points also indicated ( Fig. S5a-d in the ESM present magnified views of the samples.). While some of the sampling locations differed in height by as much as 1.9 mm, and some samples as narrow as 1 mm, all locations were sampled successfully by using 4 μL of 50/50/0.1 (v/v/v) water/ACN/FA. The relative amount of AZ-3 in the different tissue samples analyzed was determined from the chromatographic peak areas (ESM Fig. S5e ) and is displayed as a linear intensity heat map in Fig. 4b . Based on data obtained in a previous study [17] , it was expected, and the data here confirmed, that liver from dosed animal exhibited significantly larger amount of AZ-3 than muscle tissue from the same specimen. Calculated relative liver-to-muscle ratio of parent drug was 4.9 (±3.3). This ratio was somewhat lower than the ratio of 9.13 obtained from HPLC-ESI-MS/MS analysis of tissue homogenates and of 9.5 (±2.2) from direct liquid microjunction/ESI-MS/MS-based sampling of thin tissues [17] . This difference could be due in part to the aging of the samples (>5 years storage of samples used for measurements in [17] ) or the fact that the current method analyzed the surface of a tissue while HPLC-ESI-MS/MS analysis used a tissue homogenate and the previously employed surface sampling method utilized a thin tissue section. Nonetheless, the present results demonstrate for the first time that reliable sampling of crude cut tissue samples can be accomplished by the current automated setup to provide semiquantitative data on exogenous analyte content.
Conclusion
In this paper, we described the setup and capabilities of our discrete droplet liquid microjunction surface sampling system employing a commercially available CTC PAL autosampler. Addition of a laser distance sensor provided unattended analysis of samples and sample locations of dramatically disparate height, software modifications improved the spatial resolution of sampling spot selection from 1.0 to 0.1 mm, and an open bed tray system and custom sample/solvent holders allowed Fig. 4 a Scanned optical image of muscle and liver samples of a non-dosed mouse and a mouse dosed with AZ-3 (50 mg/kg, dosed subcutaneously, sacrificed 2 h after dose) showing locations sampled (black crosses) and relative height differences in millimeters from one of the dosed muscle sample. b Heat map of cpd AZ-3 (peak, R t =5.3− 5.8 min; background, R t =1− 1.5 min). The linear intensity color scale used to create the heat map is shown in the bottom section; 100 % intensity corresponds to 7.50×10 6 counts samples as large as whole-body rat thin tissue sections that shorten sampling time by about 40 %. These new features were demonstrated by spatially resolved sampling, separation, and detection of propranolol and its phase II metabolite hydroxypropranolol glucuronide, and phase II metabolite acetaminophen sulfate from whole-body rat thin tissue sections, and a proprietary drug (AZ-3) from razor blade cut "crude" organs from drug-dosed mice. Two further improvements are envisioned for the near future. One of them focuses on integrating the control of the autosampler into LMJ Points Plus© to enable sampling of a surface location right after its height is determined, eliminating any complications associated with time-dependent height changes. The other area of focus targets reliable quantitation. The present analysis approach currently only provides a relative quantitative distribution of the analyte of interest. The signal observed for a compound does not reflect the absolute amount of material present at a given location. The incorporation of internal standards to compensate for matrix-specific suppressive effects and instrument response, maximizing analyte recovery from various surface types along with calibration curves employing suitable matrices, are key aspects for quantitation that are under investigation. The ability to accurately determine the concentrations of spatially distributed drugs and metabolites in tissue from small animal models and/or clinical samples will be of significantly more utility than semiquantitative data.
